CINECA IRIS Institutional Research Information System

DE BORTOLI, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.198
AS - Asia 8.178
EU - Europa 5.245
SA - Sud America 1.462
AF - Africa 332
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 9
Totale 29.455
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.798
SG - Singapore 2.796
CN - Cina 2.038
IT - Italia 1.928
HK - Hong Kong 1.330
BR - Brasile 1.155
VN - Vietnam 782
SE - Svezia 561
DE - Germania 502
GB - Regno Unito 410
BG - Bulgaria 389
FR - Francia 307
FI - Finlandia 295
CA - Canada 258
IN - India 218
RU - Federazione Russa 203
TR - Turchia 175
KR - Corea 169
JP - Giappone 150
AT - Austria 134
AR - Argentina 109
UA - Ucraina 103
BD - Bangladesh 102
CI - Costa d'Avorio 92
NL - Olanda 90
MX - Messico 79
PL - Polonia 70
IQ - Iraq 62
ID - Indonesia 61
ZA - Sudafrica 57
CH - Svizzera 54
ES - Italia 51
EC - Ecuador 41
PK - Pakistan 40
BE - Belgio 35
SA - Arabia Saudita 35
VE - Venezuela 32
MA - Marocco 31
UZ - Uzbekistan 29
CO - Colombia 28
SN - Senegal 28
AU - Australia 27
NG - Nigeria 26
CL - Cile 24
IR - Iran 24
EG - Egitto 22
PY - Paraguay 22
PE - Perù 21
UY - Uruguay 20
JO - Giordania 19
LT - Lituania 18
MY - Malesia 17
PH - Filippine 17
PT - Portogallo 17
KE - Kenya 16
TN - Tunisia 16
CZ - Repubblica Ceca 14
DZ - Algeria 14
IL - Israele 14
NO - Norvegia 13
TH - Thailandia 12
AZ - Azerbaigian 11
NP - Nepal 11
PA - Panama 10
AE - Emirati Arabi Uniti 9
JM - Giamaica 9
LB - Libano 9
BO - Bolivia 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
CR - Costa Rica 7
GR - Grecia 7
OM - Oman 7
RS - Serbia 7
SK - Slovacchia (Repubblica Slovacca) 7
TW - Taiwan 7
EU - Europa 6
IE - Irlanda 6
KG - Kirghizistan 6
AL - Albania 5
BB - Barbados 5
DK - Danimarca 5
GT - Guatemala 4
HN - Honduras 4
HU - Ungheria 4
KZ - Kazakistan 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
BJ - Benin 3
GA - Gabon 3
GE - Georgia 3
KH - Cambogia 3
PS - Palestinian Territory 3
QA - Qatar 3
AO - Angola 2
BS - Bahamas 2
BW - Botswana 2
Totale 29.417
Salva come PNG Salva come JPEG
Città #
Ashburn 1.549
Singapore 1.516
Hong Kong 1.304
Fairfield 1.097
Woodbridge 1.035
San Jose 902
Santa Clara 872
Houston 796
Ann Arbor 759
Dallas 748
Chandler 616
Seattle 495
Shanghai 489
Serra 457
Milan 398
Cambridge 396
Sofia 388
Wilmington 385
Beijing 376
New York 326
Boardman 258
Los Angeles 229
Hefei 221
Ho Chi Minh City 205
Princeton 184
London 175
Ottawa 173
Council Bluffs 162
Lauterbourg 160
Seoul 158
Lawrence 153
Medford 146
Helsinki 140
Hanoi 134
Tokyo 131
Munich 117
Jacksonville 109
Vienna 102
Nanjing 99
Florence 95
Dong Ket 94
São Paulo 94
Abidjan 92
Des Moines 90
Redondo Beach 87
Dearborn 85
Istanbul 75
Frankfurt am Main 74
Lucca 74
Buffalo 73
Izmir 62
Pisa 61
Rome 61
San Diego 53
Orem 51
Redwood City 47
Atlanta 45
Bern 43
Turku 42
Chicago 41
Nanchang 41
Nuremberg 41
Warsaw 39
Haiphong 36
Hyderabad 36
Chennai 35
Belo Horizonte 34
Phoenix 34
Brussels 32
Denver 30
Düsseldorf 30
Ogden 30
Changsha 29
Falls Church 29
Tashkent 29
Dakar 28
Washington 28
Johannesburg 27
Amsterdam 26
Fuzhou 26
Rio de Janeiro 26
Shenyang 26
Toronto 26
Baghdad 25
Lagos 25
Kunming 24
Brooklyn 23
Dhaka 23
Bremen 22
Lancaster 22
Da Nang 21
Falkenstein 21
Guangzhou 21
Stockholm 21
Curitiba 19
Hebei 19
Manchester 19
Montreal 19
Paris 19
Brasília 18
Totale 20.478
Salva come PNG Salva come JPEG
Nome #
Evaluation of Pancreatic Exocrine Function in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas 530
Management of Chronic constipation in general practice 265
Symptom analysis improves GERD diagnosis and may be helpful to define a successful surgical approach 262
Gastroesophageal reflux symptoms among Italian university students: Epidemiology and dietary correlates using automatically recorded transactions 253
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study 239
Lactobacillus Casei DG® in Patients with Irritable Bowel Syndrome: Not Only a Change of the Gut Microbiota. A Pilot Study 235
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 226
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 219
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group 216
Not all anti-reflux treatment failures are due to persistence of abnormal esophageal acid exposure 209
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics 209
Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease 204
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome 203
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease 194
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 194
Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique 194
Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori 193
The Revised Reflux Symptom Index (R-RSI): Development, Internal and External Validation Study 191
Irritable bowel syndrome and chronic constipation: Fact and fiction 190
Low FODMAP diet: Evidence, doubts, and hopes 190
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 188
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? 188
Association between baseline impedance values and response proton pump inhibitors in patients with heartburn 188
Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: Common overlapping gastrointestinal disorders 186
Management of chronic constipation in general practice. 185
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: A comparative study 183
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 181
Subthreshold psychiatric psychopathology in Functional gastrointestinal disorders: Can it be the bridge between gastroenterology and psychiatry? 179
Could double-dose PPI therapy modify tissutal homeostasis in patients with barrett esophagus? 178
Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding 178
Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring 178
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 177
Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance 177
Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults 176
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine 175
Eating habits trajectories of students using university canteens 175
Suspected laryngopharyngeal reflux evaluated with multichannel impedance and Ph-monitoring. How many are gerd patients? 174
Radionuclide evaluation of the lower gastrointestinal tract 174
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure 174
Clinical and pathophysiological outcomes of the robotic-assisted Heller–Dor myotomy for achalasia: a single-center experience 173
Refractory Gastroesophageal Reflux Disease: A Management Update 173
“PancPro” as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases 172
Esophageal motility abnormalities in gastroesophageal reflux disease 172
The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment 172
Presbifagia Esofagea 172
Updates in the field of non-esophageal gastroesophageal reflux disorder 172
Oral sucrosomial iron is as effective as intravenous ferric carboxy‐maltose in treating anemia in patients with ulcerative colitis 172
Vegetal and Animal Food Proteins Have a Different Impact in the First Postprandial Hour of Impedance-pH Analysis in Patients with Heartburn 171
Barrett's esophagus in 2016: From pathophysiology to treatment 170
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 169
Esophageal testing: What we have so far 166
Advancements in the use of manometry and impedance testing for esophageal functional disorders 166
Vonoprazan fumarate for the management of acid-related diseases 165
Nuclear translocation of GSTO is a progression marker in Barrett’s esophagus. 164
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations 163
Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis 162
Assessment of bowel wall inflammation in Crohn's disease by a new quantitative ultrasound analysis as compared to vascularization in healthy volunteers bowel wall. 160
Alginate controls heartburn in patients with erosive and nonerosive reflux disease 160
Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn 160
Eosinophilic esophagitis: Update in diagnosis and management. Position paper by the Italian Society of Gastroenterology and Gastrointestinal Endoscopy (SIGE) 160
Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio 159
Assessment of the anti-reflux properties and therapeutic efficacy of Faringel in patients with mild to moderate GERD. 158
Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus 158
Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective Study 156
Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study 156
Diets including Animal Food Are Associated with Gastroesophageal Reflux Disease 155
Evaluation of latent links between irritable bowel syndrome and sleep quality 155
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. 155
Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights 154
Achalasia with dense eosinophilic infiltrate responds to steroid therapy 154
Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn’s Disease 153
Ambulatory pH-Impedance Findings Confirm That Grade B Esophagitis Provides Objective Diagnosis of Gastroesophageal Reflux Disease 153
Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors 153
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 153
Low fermentable oligo-di-and mono-saccharides and polyols (Fodmaps) or gluten free diet: What is best for irritable bowel syndrome? 153
Gastrointestinal involvement in systemic sclerosis 152
The natural history of gastro-esophageal reflux disease: A comprehensive review 152
A low-FODMAP diet for irritable bowel syndrome: Some answers to the doubts from a long-term follow-up 152
Lactoferrin and probiotic can improve Helicobacter pylori eradication rate of triple standard therapy. 151
Serum pepsinogen I and gastrin-17 levels are predictable of atrophic gastritis in patients with autoimmune thyroiditis and anti-gastric parietal cell autoantibodies. 151
The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring 151
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD 151
Interstitial lung disease in systemic sclerosis patients may benefit more from anti-reflux therapies than from immunosuppressants 151
High-resolution manometry is superior to endoscopy and radiology in assessing and grading sliding hiatal hernia: A comparison with surgical in vivo evaluation 151
High Resolution and High Definition Anorectal Manometry 151
Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations 151
GSTO: new marker of progression from barrett’s esophagus to adenocarcinoma. 148
Current and future perspectives in the management of gastroesophageal reflux disease 146
Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0© 146
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD 145
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) 145
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough 144
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 144
Esophageal dysmotility in patients with eosinophilic esophagitis: pathogenesis, assessment tools, manometric characteristics, and clinical implications 143
Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study 143
Perceptual and multiparametric analysis of the voice in GERD patients 143
Are PPI responder patients always confirmed as GERD patients? A MII-PH study. 142
Is gluten the only culprit for non-celiac gluten/wheat sensitivity? 141
Optimal management of constipation associated with irritable bowel syndrome 140
Assessment and Diagnostic Accuracy Evaluation of the Reflux Symptom Index (RSI) Scale: Psychometric Properties using Optimal Scaling Techniques 139
Totale 17.542
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.601
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.601
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021347 0 0 0 0 0 0 0 0 0 0 102 245
2021/20221.652 17 76 37 68 322 258 59 80 104 64 92 475
2022/20232.078 265 305 176 153 200 311 19 149 325 13 134 28
2023/20241.849 183 183 235 168 226 310 91 57 45 50 81 220
2024/20257.009 85 237 187 388 564 721 531 374 751 888 846 1.437
2025/20269.292 682 1.118 1.086 1.013 924 764 1.287 518 649 1.023 228 0
Totale 30.055